The AquilionONE is a new advanced diagnostic imaging system by Toshiba America
Medical Systems that leverages dynamic volume computed tomography (CT) imaging to capture an entire organ in a single rotation or over multiple rotations to show real-time dynamic movement.
Additionally, multiphase studies, such as perfusion of the brain, heart and other organs, are possible with the AquilionONE. The system covers up to 16 centimeters of anatomy using 320 ultra high-resolution 0.5-millimeter
detector elements, producing images designed to promote greater clinical accuracy.

February 4, 2008 - Tryton Medical Inc. said it has received CE Mark approval for its Side-Branch Stent, a cobalt chromium balloon-expandable coronary stent specifically developed for the complete treatment of the entire spectrum of coronary artery bifurcation disease.

Approximately 540,000 annual procedures are performed to address bifurcation lesions, accounting for 20% of all coronary lesions treated. With the exception of Tryton's stent, no dedicated solution exists today that fully addresses these lesions, according to the company.

February 5, 2008 - Mitralign Inc. said it successfully performed its first implantation of the Mitralign Percutaneous Annuloplasty System for mitral valve repair at French Hospital in Asuncion, Paraguay.

February 5, 2008 - CytoCore Inc. said today that the FDA has approved the company's 510(k) submission to sell CytoCore's SoftPAP cervical cell collector.

The SoftPAP collects more comprehensive and complete cervical cell specimens for Pap testing, according to CytoCore.

February 5, 2008 - Endologix Inc., developer and manufacturer of the Powerlink System endoluminal stent graft (ELG) for the minimally invasive treatment of abdominal aortic aneurysms (AAA), today noted a study published in the Jan. 31 issue of the New England Journal of Medicine comparing results of AAA repair following open surgery and endovascular repair.

February 4, 2008 - CV Therapeutics Inc. and Medlogics Device Corporation announced today that the companies have entered into an agreement under which Medlogics has licensed CV Therapeutics’ proprietary biopolymer stent coating technology to develop a drug eluting stent (DES).

February 5, 2008 - New polymer material designed to stop bone bleeding in surgery reduces the risk of surgical infection, according to a new animal study to be published in the Feb. 2008 issue of Clinical Orthopaedics and Related Research (CORR).

The study has implications for lowering the risk of hospital-acquired infections, including MRSA.

February 4, 2008 - Misonix Inc., a developer of minimally invasive ultrasonic medical device technology for the ablation of cancer and other chronic health conditions, today said that it has entered into a distribution agreement with Aesculap Inc., a subsidiary of B. Braun, for the domestic distribution of the Misonix BoneScalpel, a new Ultrasonic Osteotome (or bone cutting device) for use in orthopedic and neurological applications related to the spine and cranium.

For more information: www.misonix.com

February 5, 2008 - Patients with diabetes, cardiac problems, kidney disorders or high blood pressure could benefit from the development of new hologram technology.

The new “smart” holograms, which can detect changes in, for example, blood-glucose levels, should make self-diagnosis much simpler, cheaper and more reliable, write Chris Lowe and Cynthia Larbey in February's Physics World.

February 5, 2008 – During the 2008 HIMSS event in Feb. 24-25 in Orlando, CSC will release a new report that lays out a progress report for the healthcare industry on utilizing emerging technologies to tackle issues of patient care, improving efficiency at a time of more patients and fewer providers and increasing transparency relating to cost and quality.

The report is an outgrowth of CSC’s acquisition of First Consulting Group (FCG), and will be bolstered by the release of new research and three presentations during the conference’s education programming.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now